BRAINSTORM CELL THERAPEUTICS INC.
For the period ended May 25, 2026. Filed May 28, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 25, 2026 · Filed May 28, 2026
Use the contents to explore the available documents and sections.
BCLI$1.14-7.3%Stored close · as of Jul 8, 2026
Opening this filing…
The words and numbers in each frame are the filing's, as the company filed them with the SEC. Where a filing is data, we made the labels and headings from its field names, and added commas to its long numbers. This is not investment advice.